Climate Change Data

Catalyst Pharmaceuticals, Inc.

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Product Quality & Patient Safety
  • Access to Healthcare
  • Employee Engagement
  • Supply Chain Management
  • Corporate Governance
  • Environmental Sustainability
  • Community Involvement

Environmental Achievements

  • Located in a LEED silver certified green building with energy-efficient practices and waste reduction initiatives.
  • Implemented a hybrid working model reducing employee commute emissions.

Social Achievements

  • Launched Catalyst Pathways®, a patient services program offering financial and educational resources.
  • Maintained low employee turnover (13.3%).
  • Supported various charities through donations and employee volunteer efforts.
  • Expanded FIRDAPSE® approval to include pediatric patients ages six and older.

Governance Achievements

  • Established a Corporate Responsibility Steering Committee to oversee ESG initiatives.
  • Implemented a Code of Conduct and Business Ethics with annual employee training.
  • Maintained zero monetary losses from legal proceedings related to false marketing claims or corruption.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Measure and report Scope 1 and 2 emissions.
  • Improve environmental program reporting and transparency.

Environmental Challenges

  • Measuring and reporting Scope 1 and 3 emissions.
  • Expanding environmental program and reporting transparency.
  • Maintaining product quality and safety throughout the supply chain.
  • Ensuring access to affordable medicines for all patients.
Mitigation Strategies
  • Engaging with suppliers on ESG issues.
  • Implementing a formal process to measure and monitor GHG emissions and energy consumption.
  • Conducting thorough supplier assessments and providing training.
  • Offering various financial assistance programs to reduce patient costs.

Supply Chain Management

Supplier Audits: 29% of Tier 1 suppliers participate in the Rx-360 audit program.

Responsible Procurement
  • Thorough supplier assessments to ensure compliance with GMP and relevant regulations.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: SASB, GRI, UN SDGs

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Good Health and Well-being
  • Quality Education
  • Gender Equality
  • Decent Work and Economic Growth
  • Industry, Innovation and Infrastructure
  • Reduced Inequalities
  • Climate Action
  • Peace, Justice and Strong Institutions
  • Partnerships for the Goals

Catalyst's initiatives contribute to these goals through various programs and policies related to patient care, employee development, diversity and inclusion, environmental sustainability, ethical business practices, and community engagement.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Ranked ninth on Forbes 2023 list of America’s Best Small Companies.
  • Named 2022 BioFlorida Company of the Year.

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:1.8 metric tons (directed to disposal)
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Operates in a LEED Gold-certified green building with high ENERGY STAR rating (91/100), implementing energy conservation, waste management, and water conservation measures.

Social Achievements

  • Expanded workforce from 75 in 2022 to 164 in 2023; 9.1% employee turnover rate (4.2% decrease from 2022); launched and expanded Catalyst Pathways® patient services program; increased awareness of LEMS among SCLC patients; made charitable donations of $5,900,000.

Governance Achievements

  • Established Corporate Responsibility Steering Committee; maintained high Board and committee meeting attendance rates; tied executive compensation to measurable ESG goals; zero incidents of corruption or bribery; zero cybersecurity incidents.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Expanding global presence and increasing ESG regulations; measuring and reporting Scope 1 and 2 emissions; managing risks associated with supply chain disruptions and counterfeit drugs.
Mitigation Strategies
  • Undertaking preparedness activities to align with TCFD recommendations; establishing a structured data collection system for energy usage and GHG emissions; implementing annual supplier assessments and training; employing a stringent limited distribution system for FIRDAPSE® and AGAMREE®; adhering to GS1 product serialization standards.

Supply Chain Management

Supplier Audits: 63% of Tier 1 suppliers participate in Rx-360 audit program; 63% of Tier 1 suppliers have ISO 140001 or HAZWOPER certification.

Responsible Procurement
  • Comprehensive supplier assessments; onboarding and annual refresher training; adherence to cGMP and FDA regulations; monitoring for environmental compliance.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: SASB, GRI, UN SDGs

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Goal 3 (Good Health and Well-being)
  • Goal 4 (Quality Education)
  • Goal 5 (Gender Equality)
  • Goal 8 (Decent Work and Economic Growth)
  • Goal 9 (Industry, Innovation and Infrastructure)
  • Goal 10 (Reduced Inequalities)
  • Goal 13 (Climate Action)
  • Goal 16 (Peace, Justice and Strong Institutions)
  • Goal 17 (Partnerships for the Goals)

Initiatives contributing to these goals are described in the UN SDG Alignment section of the report.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Ranked 4 out of 100 on Forbes 2024 List of America’s Most Successful Small-Cap Companies; Achieved “BBB” MSCI rating.